YIH
MDLN

Y-Intercept (HK)’s Medline Inc MDLN Stock Holding History

Y-Intercept (HK)’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,875
Closed -$973K – 2276
2026
Q1 		$973K Buy
21,875
+5,889
+37% +$260K 0.02% 1044
2025
Q4 		$671K Buy
+15,986
New +$675K 0.02% 1143

Other funds holding MDLN

ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
PFM
Premier Fund Managers Guildford, United Kingdom $1.1B AUM 14.42% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
CAM
Clio Asset Management Charlottesville, Virginia $126M AUM 16.01% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
FAMI
Fideuram Asset Management (Ireland) Dublin 1 $5.26B AUM

Y-Intercept (HK)'s MDLN Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Medline Inc (MDLN) in Q2 2026, closing a stake of 21,875 shares — an estimated $973K sold.

Y-Intercept (HK) first reported a position in MDLN in Q4 2025 and held it in 2 quarters. The position peaked at $973K in Q1 2026. 68 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Y-Intercept (HK) reported no remaining Medline Inc position as of Q2 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 21,875 Medline Inc shares in Q2 2026, an estimated $973K.
  • Y-Intercept (HK) first reported a position in Medline Inc in Q4 2025 and held it in 2 quarters.
  • Y-Intercept (HK)'s Medline Inc position peaked at $973K in Q1 2026.
  • 68 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.